Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Chinese Journal of Cancer|June 25, 2016
Chemotherapy in non-small cell lung cancer: opportunities for advancementMani Akhtari, Eric H Bernicker, Bin S TehJournal of Thoracic Disease|February 19, 2019
Update on emerging biomarkers in lung cancerEric H Bernicker, Timothy Craig Allen, Phillip T CagleJTO Clinical and Research Reports|September 30, 2021
Hyperprogressive NSCLC With Two Immune-Checkpoint InhibitorsSaro Kasparian, Cesar Gentille, Ethan Burns, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 5, 2024
Effect of direct oral anticoagulants compared to enoxaparin on objective response to immune checkpoint inhibitors in patients with lung cancerSolmaz Karimi, Karen Abboud, Godsfavour Umoru, et al.Current Opinion in Gastroenterology|January 3, 2020
Cancer cachexia: a multifactoral disease that needs a multimodal approachRenee Stubbins, Eric H Bernicker, Eamonn M M QuigleyJACC. Cardiooncology|August 16, 2021
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)Kartik Anand, Joe Ensor, Barry Trachtenberg, et al.Journal of Oncology Practice|April 12, 2017
Biomarkers for Selection of Therapy for Adenocarcinoma of the LungEric H Bernicker, Ross A Miller, Phillip T CagleFrontiers in Oncology|October 30, 2023
Lung adenocarcinoma in a patient with Lynch syndrome: a case report and literature reviewAlan Hodges, Kai Sun, Tiffany G Sheu, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 9, 2019
Relationship between clinical features, GEP class, and PRAME expression in uveal melanomaAmy C Schefler, Emre Koca, Eric H Bernicker, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 2, 2018
Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer centerJenna M Solomon, Veronica B Ajewole, Amy M Schneider, et al.Pageof 5